RGLS. Regulus Presents New Preclinical Data on miR-21 at Kidney Week 2012 -Regulus, in partnership with Sanofi, is developing novel anti-fibrotic therapies targeting microRNAs- http://finance.yahoo.com/news/regulus-presents-preclinical-data-mir-170000792.html stockcharts.com/c-sc/sc?s=RGLS&p=D&yr=0&mn=2&dy=0&i=t80203351537&r=1351994957727